Who
Sam Lee
President and Co-CEO
Company insider
Files Form 4 as: President and Co-CEO, Cocrystal Pharma.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $968K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Mar 2015
- Last trade
- 9 Jan 2026
- Last filed
- 13 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jan 2026filed 13 Jan 2026 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,229 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,229 at $0.00 | filing |
| 9 Oct 2024filed 11 Oct 2024 | COCP Cocrystal PharmaBiotechnology | SEC FORM 4 Code A | —40,000 | filing |
| 18 Jul 2023filed 20 Jul 2023 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 Jul 2022filed 3 Aug 2022 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 16 Jul 2021filed 20 Jul 2021 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 24 Nov 2020filed 12 Feb 2021 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Jun 2020filed 24 Jun 2020 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 21 Sep 2018filed 24 Sep 2018 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 23 Dec 2016filed 23 Dec 2016 | COCP Cocrystal PharmaBiotechnology | SEC FORM 4 Sold | $968K2,200,000 at $0.44 | filing |
| 3 Mar 2015filed 5 Mar 2015 | COCP Cocrystal PharmaBiotechnology | SEC FORM 4 Code M | —15,287,847 | filing |
| 3 Mar 2015filed 5 Mar 2015 | COCP Cocrystal Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —74,545 | filing |
News
No headline names them, or the companies they trade most, lately.